Paper2069366
Antibacterial activities and modes of action of vancomycin and related glycopeptides.
Nagarajan R. Antimicrob Agents Chemother, 1991. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Antibacterial activities and modes of action of vancomycin and related glycopeptides. Papers, record 2069366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2069366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bacteria | Major topic |
| Glycopeptides | Major topic |
| Vancomycin | Major topic |
| Structure-Activity Relationship |
Source PubMed
References19
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 5967114 | Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin. | Biochem Biophys Res Commun | 1966 | https://conductscience.org/library/papers/5967114 | PubMed |
| 2 | 14324547 | LIPID-PHOSPHOACETYLMURAMYL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS. | Proc Natl Acad Sci U S A | 1965 | https://conductscience.org/library/papers/14324547 | PubMed |
| 3 | 6548221 | A51568A: N-demethylvancomycin. | J Antibiot (Tokyo) | 1984 | https://conductscience.org/library/papers/6548221 | PubMed |
| 4 | 6238927 | Teicoplanin, antibiotics from Actinoplanes teichomyceticus nov. sp. VI. Chemical degradation: physico-chemical and biological properties of acid hydrolysis products. | J Antibiot (Tokyo) | 1984 | https://conductscience.org/library/papers/6238927 | PubMed |
| 5 | 6240963 | Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus nov. sp. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6240963 | PubMed |
| 6 | 2869019 | Aridicins, novel glycopeptide antibiotics. III. Preparation, characterization, and biological activities of aglycone derivatives. | J Antibiot (Tokyo) | 1986 | https://conductscience.org/library/papers/2869019 | PubMed |
| 7 | 2942100 | Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/2942100 | PubMed |
| 8 | 3781910 | Kibdelins (AAD-609), novel glycopeptide antibiotics. II. Isolation, purification and structure. | J Antibiot (Tokyo) | 1986 | https://conductscience.org/library/papers/3781910 | PubMed |
| 9 | 3624076 | Parvodicin, a novel glycopeptide from a new species, Actinomadura parvosata: discovery, taxonomy, activity and structure elucidation. | J Antibiot (Tokyo) | 1987 | https://conductscience.org/library/papers/3624076 | PubMed |
| 10 | 2891921 | Vancomycin-resistant enterococci. | Lancet | 1988 | https://conductscience.org/library/papers/2891921 | PubMed |
| 11 | 3403380 | New glycopeptide antibiotics. I. The structures of orienticins. | J Antibiot (Tokyo) | 1988 | https://conductscience.org/library/papers/3403380 | PubMed |
| 12 | 3192496 | Synthesis and antibacterial activity of N-acyl vancomycins. | J Antibiot (Tokyo) | 1988 | https://conductscience.org/library/papers/3192496 | PubMed |
| 13 | 3272137 | New glycopeptide antibiotics: II. The isolation and structures of chloroorienticins. | J Antibiot (Tokyo) | 1988 | https://conductscience.org/library/papers/3272137 | PubMed |
| 14 | 2921228 | Synthesis and antibacterial evaluation of N-alkyl vancomycins. | J Antibiot (Tokyo) | 1989 | https://conductscience.org/library/papers/2921228 | PubMed |
| 15 | 2817848 | Activity of glycopeptides against vancomycin-resistant gram-positive bacteria. | Antimicrob Agents Chemother | 1989 | https://conductscience.org/library/papers/2817848 | PubMed |
| 16 | 2532132 | Structure, biochemistry and mechanism of action of glycopeptide antibiotics. | Eur J Clin Microbiol Infect Dis | 1989 | https://conductscience.org/library/papers/2532132 | PubMed |
| 17 | 2113517 | MM 45289, a potent glycopeptide antibiotic which interacts weakly with diacetyl-L-lysyl-D-alanyl-D-alanine. | J Antibiot (Tokyo) | 1990 | https://conductscience.org/library/papers/2113517 | PubMed |
| 19 | 14287259 | STRUCTURE STUDIES ON VANCOMYCIN. | J Med Chem | 1965 | https://conductscience.org/library/papers/14287259 | PubMed |
| 20 | 6027793 | Biosythesis of the peptidoglycan of bacterial cell walls. II. Phospholipid carriers in the reaction sequence. | J Biol Chem | 1967 | https://conductscience.org/library/papers/6027793 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41961464 | Chitooligosaccharide-based hydrogel microneedle for the effective transdermal delivery of vancomycin. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/41961464 | PubMed |
| 41161584 | The antiarrhythmic drugs dronedarone and amiodarone exhibit potent in vitro and in vivo activity against Clostridioides difficile. | Int J Antimicrob Agents | 2026 | https://conductscience.org/library/papers/41161584 | PubMed |
| 40757024 | Pharmacotherapy variability and precision medicine in neurocritical care. | Front Neurol | 2025 | https://conductscience.org/library/papers/40757024 | PubMed |
| 40666031 | Fluorescent Antibiotics: Bridging Diagnostic and Therapy in the Fight against Bacterial Infections. | Small Sci | 2025 | https://conductscience.org/library/papers/40666031 | PubMed |
| 39902442 | Hypothesizing Protocol for Soft Tissue Rejuvenation of Comminuted Maxillofacial Fractures with Glycopeptide Antibiotic. | J Maxillofac Oral Surg | 2025 | https://conductscience.org/library/papers/39902442 | PubMed |
| 39600109 | Vancomycin population pharmacokinetic models: Uncovering pharmacodynamic divergence amid clinicobiological resemblance. | CPT Pharmacometrics Syst Pharmacol | 2025 | https://conductscience.org/library/papers/39600109 | PubMed |
| 38578803 | Comparison of qPCR and metagenomic sequencing methods for quantifying antibiotic resistance genes in wastewater. | PLoS One | 2024 | https://conductscience.org/library/papers/38578803 | PubMed |
| 38560705 | Inhibiting Peptidoglycan Hydrolase Alleviates MRSA Pneumonia Through Autolysin-Mediated MDP-NOD2 Pathway. | Infect Drug Resist | 2024 | https://conductscience.org/library/papers/38560705 | PubMed |
| 37093913 | Analysis of antibiotic resistance genes in pig feces during the weaning transition using whole metagenome shotgun sequencing. | J Anim Sci Technol | 2023 | https://conductscience.org/library/papers/37093913 | PubMed |
| 36134162 | Staphylococcus aureus entanglement in self-assembling β-peptide nanofibres decorated with vancomycin. | Nanoscale Adv | 2021 | https://conductscience.org/library/papers/36134162 | PubMed |
| 35675307 | Staphylococcus aureus cell wall maintenance - the multifaceted roles of peptidoglycan hydrolases in bacterial growth, fitness, and virulence. | FEMS Microbiol Rev | 2022 | https://conductscience.org/library/papers/35675307 | PubMed |
| 35539660 | Diaryl ethers synthesis: nano-catalysts in carbon-oxygen cross-coupling reactions. | RSC Adv | 2018 | https://conductscience.org/library/papers/35539660 | PubMed |
| 35126378 | Effect of D-Ala-Ended Peptidoglycan Precursors on the Immune Regulation of Lactobacillus plantarum Strains. | Front Immunol | 2021 | https://conductscience.org/library/papers/35126378 | PubMed |
| 34834215 | Development of Novel Peptides for the Antimicrobial Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Infection. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/34834215 | PubMed |
| 34697316 | Antibiotic-chemoattractants enhance neutrophil clearance of Staphylococcus aureus. | Nat Commun | 2021 | https://conductscience.org/library/papers/34697316 | PubMed |
| 32269153 | First Report of the Local Spread of Vancomycin-Resistant Enterococci Ascribed to the Interspecies Transmission of a vanA Gene Cluster-Carrying Linear Plasmid. | mSphere | 2020 | https://conductscience.org/library/papers/32269153 | PubMed |
| 24236721 | Progress in the discovery of treatments for C. difficile infection: A clinical and medicinal chemistry review. | Curr Top Med Chem | 2014 | https://conductscience.org/library/papers/24236721 | PubMed |
| 23028676 | mMass as a software tool for the annotation of cyclic peptide tandem mass spectra. | PLoS One | 2012 | https://conductscience.org/library/papers/23028676 | PubMed |
| 22514280 | Lipodepsipeptide empedopeptin inhibits cell wall biosynthesis through Ca2+-dependent complex formation with peptidoglycan precursors. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22514280 | PubMed |
| 22314525 | Product quality of parenteral vancomycin products in the United States. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22314525 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2069366
GET https://conductscience.org/api/papers/v1/2069366/cited_by?page=2